News and Publications:
- Election to Board of Directors: The Principals of NorthStar Capital Advisors are pleased to announce the election of Alex Charlton (Managing Director, NorthStar) to the Board of Directors of Genetics Squared, Inc. a leading developer of innovative Molecular Diagnostics targeting cancer (click on the Navigation Menu, on the right of this page, to find out more)
- Prospectus Now Available - Access to Capital, Free-Trade Zone & Tax Incentives: NorthStar Capital Advisors announces access to qualifying Life Science sector companies to compelling tax incentives, a world-class free-trade zone (enabling the deferral, reduction and in some instances the elimination of all Customs duties and federal excise taxes), commercial infrastructure and investment capital(click on the Navigation Menu, on the right of this page, to find out more)
- SpineView: NorthStar Capital Advisors, in collaboration with Windham Venture Partners, assisted in the completion of an $18 million financing for the California headquartered spinal tissue repair company, SpinView, Inc. Founded by Lewis C. Pell and Roy Chin (CEO and formerly of AFx Inc. and Stryker Corporation), SpinView is developing and commercializing an innovative, market disruptive portfolio of minimally invasive spinal repair devices. Earlier this year SpineView secured 2 FDA regulatory approvals and they have commenced sales in the United States.
- Europa Partners Limited: Alex Charlton, Managing Director of NorthStar, has been appointed in a personal capacity as an independent Advisor to Europa Partners Limited, a corporate finance advisory firm headquartered in London. Wholly owned by the partners, Europa Partners provides objective corporate finance advice free from the conflicts inherent in a multi-product or capital market focused firm. Europa's partners have advised on transactions across five continents and have an extensive set of relationships with corporates, institutions and intermediaries worldwide.
- Windham Venture Partners: NorthStar Capital Advisors have been appointed advisors to New York headquartered Windham Venture Partners. Windham Venture Partners is a Life Sciences technology commercialization firm. Examples of Windham's private equity investments include SpineView (minimally-invasive spinal tissue repair technology), GlySens (non-invasive, real-time blood glucose monitoring), Aura (light-activated Tissue Repair system uses a photo-responsive dye and visible light to create a instant water-tight union/seal) and Genetics Squared (molecular diagnostics and prognostics targeting cancer and cardiovascular diseases). Windham Venture Partners also act as founder, investor and initial management for portfolio companies.